Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
• NP276005.RAXSlCeMBq5-jYsWCBjad1r9ym4IsydCvWewsIE4SGsio130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276005.RAXSlCeMBq5-jYsWCBjad1r9ym4IsydCvWewsIE4SGsio130_provenance.
• NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.
• NP926066.RAASzMY1uK4q26REHGnFR4amWillIthAprkekivFon0jg130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926066.RAASzMY1uK4q26REHGnFR4amWillIthAprkekivFon0jg130_provenance.
• NP276007.RAqgkzkiQzh_Osj3w_sT6mKthr9eBi3dgQ0SBtBj2thbg130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276007.RAqgkzkiQzh_Osj3w_sT6mKthr9eBi3dgQ0SBtBj2thbg130_provenance.
• NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.
• NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.
• NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.